Miguel Giovanni Uriol Rivera
Miguel Giovanni Uriol Rivera
NEPHROLOGY SPECIALIST
Nephrologyen/specialities/nephrology
See more specialists on
Málagamalaga
en/medical-staff/nephrologist
Dr. Miguel Giovanni Uriol Rivera is a leading specialist in Nephrology , with a solid academic background that includes a PhD in Basic Medical Sciences from the Universidad de las Islas Baleares, obtained in 2016. He currently practices at the H.QS. Málaga , where he leads outpatient nephrology clinics. His contribution to the field is reflected in his most recent publication, "PLASMIC score to aid diagnosis of aHUS: an analysis of C5 inhibitor clinical trials and the PINC AI(tm) healthcare database," published in May 2025. He has also been recognized for his Best Clinical Practices in the management of Thrombotic Microangiopathy, an award granted by the Government of the Balearic Islands in 2022. Dr. Uriol Rivera is also an active member of the Spanish Society of Nephrology , which underscores his commitment to the medical community and his ongoing professional development.
Key information
- Good Clinical Practices. Multidisciplinary Team for Thrombotic Microangiopathy2022
- Latest Publication:Acute renal failure due to sulfadiazine crystalluria.
- Belongs to:ERA-EDTA
Professional Details
Hospital Quirónsalud Málaga
SPECIALIST PHYSICIAN NEPHROLOGY
June 2025
Hospital Universitari Son Espases
Specialist doctor
January 2004
Study
Bachelor of Medicine and Surgery
University, Universidad Complutense de Madrid
2000
Doctorate
Universidad de las Islas Baleares
2016
Specialized Healthcare Training
Nephrology
Healthcare Institutions
Another qualification
University Expert in Statistics Applied to Health Sciences
University
Another qualification
Research sufficiency: MIRCERA-EPO STUDY EVALUATING THE EFFICACY OF MIRCERA(r) IN PRE-DIALYSIS PATIENTS
University
Another qualification
University Expert in Advanced Methods in Applied Statistics
University
II UPDATE COURSE IN NEUROVASCULAR PATHOLOGY
Servei de Salut de les Illes Balears
September 2015
VI Update Course and Advances in Systemic Autoimmune Diseases
Unidad de Enfermedades Autoinmunes Sistémicas
June 2011
Therapeutic management of the chronic kidney patient and transplant recipient
Hospital Universitari Son Dureta
January 2010
Continuing Education in Dialysis
Hospital Universitari Son Dureta
June 2009
Master's Degree in Medical and Health Sciences
Metabolic syndrome and cardiovascular risk
Universitat de les Illes Balears
May 2013
PIERAID Study
2013
Bigart Project
Hospital Universitario Son Espases
2017
Multidisciplinary team for the management of Thrombotic Microangiopathy
Hospital Universitario Son Espases
2016
MIR-EPO Study
2009
Clinical development of paricalcitol as an innovative treatment for anemia in chronic kidney disease
HUMAN-C Project
Acute renal failure due to sulfadiazine crystalluria.
Scientific article
Atheroembolic disease and pulmonary haemorrhage.
Scientific article
Impact of a multidisciplinary team for the management of thrombotic microangiopathy.
Scientific article
Multiple myeloma, severe hypercalcemia, acute renal failure and multiple organ failure due to calcinosis.
Scientific article
PLASMIC score to aid diagnosis of aHUS: an analysis of C5 inhibitor clinical trials and the PINC AI(tm) healthcare database.
Scientific article
Risk factors of death or chronic renal replacement therapy requirements in patients with thrombotic microangiopathy without ADAMTS-13 deficiency.
Scientific article
Sequential administration of paricalcitol followed by IL-17 blockade for progressive refractory IgA nephropathy patients.
Scientific article
Serum uric acid concentration as non-classic cardiovascular risk factor in women with polycystic ovary syndrome: Effect of treatment with ethinyl-estradiol plus cyproterone acetate versus metformin.
Scientific article
Pneumo-renal syndrome in a patient with Schonlein-Henoch vasculitis.
Scientific article
Target organ damage and cardiovascular complications in patients with hypertension and type 2 diabetes in Spain: a cross-sectional study.
Scientific article
Treatment With Cinacalcet of Secondary Hyperparathyroidism After Renal Transplantation.
Scientific article
ERA-EDTA
Sociedad Española de Nefrología
American Society of Nephrology
Sociedad Española de Medicina Interna (SEMI)
Good Clinical Practices. Multidisciplinary Team for Thrombotic Microangiopathy
Govern de les Illes Balears
Clinical benefits for hemodialysis patients: Benefits of the Paricalcitol (selective vitamin D receptor activator indicated for prevention and treatment of the secondary hyperparathyroidism) on anemia of inflammation in dialysis patients under erythropoietic stimulating agents.
Sociedad Española de Nefrología
First prize for free communication: Renal transplantation and peritoneal dialysis
SOCIEDAD ESPAÑOLA DE DIALISIS Y TRASPLANTE
Catalan
B2
English
B1
Make an appointment with this professional
Vídeos de
Consulta el contenido multimedia de este profesional.
Hospitals
Book an appointment now at one of our hospitals.
Hospital Quirónsalud Málaga
Avda. Imperio Argentina, 1
29004 Málaga
Articles on
Browse the latest articles on Tu canal de salud.
¿No tienes seguro de salud?
Con nuestros Planes de Salud Quirónsalud Connect tendrás un médico de medicina general todos los días las 24 horas. Y además gestor personal y medición facial de constantes vitales.